Category: <span>Monotherapy</span>

Category: Monotherapy

bap1, Cisplatin, Memorial Sloan-Kettering Cancer Center, mesothelioma cancer, Mesothelioma News, Monotherapy, Premetrexed, Tazemetostat

Epizyme Testing New Mesothelioma Treatment with Phase Two Clinical Trial

 

Biopharmaceutical company Epizyme, Inc. is starting a new phase two clinical trial using tazemetostat as a treatment for mesothelioma cancer.